Synergistic antifungal activities of bafilomycin A1, fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 739-746

  Del Poeta, Maurizio ^a,b,c   Cruz, M Cristina ^a   Cardenas, Maria E ^a   Perfect, John R ^a   Heitman, Joseph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BAFILOMYCIN A1; CALCINEURIN; CASPOFUNGIN; CYCLOSPORIN; CYCLOSPORIN DERIVATIVE; FLUCONAZOLE; FLUCYTOSINE; L 685818; L 743873; MULTIDRUG RESISTANCE PROTEIN; PNEUMOCANDIN DERIVATIVE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TACROLIMUS; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG MECHANISM; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CALCINEURIN; CRYPTOCOCCUS NEOFORMANS; DRUG COMBINATIONS; DRUG SYNERGISM; FLUCONAZOLE; HUMANS; IMMUNOPHILINS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC; TACROLIMUS; TACROLIMUS BINDING PROTEINS;

EID: 0033998663     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.739-746.2000     Document Type: Article

References (54)

1. Arceri, R. J., K. Stieglitz, and B. E. Bierer. 1992. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 80:1528-1536.
2. Bowman, E. J., A. Siebers, and K. Altendorf. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells. Proc. Natl. Acad. Sci. USA 85:7972-7976.
3. Breuder, T., C. S. Hemenway, N. R. Movva, M. E. Cardenas, and J. Heitman. 1994. Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. Proc. Natl. Acad. Sci. USA 91:5372-5376.
4. Cardenas, M., C. Hemenway, R. S. Muir, R. Ye, D. Florentino, and J. Heitman. 1994. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J. 13:5944-5957.
5. Cox, G. M., and J. R. Perfect. 1993. Fungal infections. Curr. Opin. Infect. Dis. 6:422-426.
6. Cruz, M. C., L. M. Cavallo, J. M. Görlach, G. Cox, J. R. Perfect, M. E. Cardenas, and J. Heitman. 1999. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol. Cell. Biol. 19:4101-4112.
7. Cruz, M. C., M. Del Poeta, P. Wang, R. Wenger, G. Zenke, V. F. J. Quesniaux, N. R. Movva, J. R. Perfect, M. E. Cardenas, and J. Heitman. 2000. Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob. Agents Chemother. 44:143-149.
8. Cruz, M. C., R. A. Sia, M. Olson, G. M. Cox, and J. Heitman. 2000. Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans. Infect. Immun. 68:982-985.
9. Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
10. Douglas, C. M., J. A. D'Ippolito, G. J. Shei, M. Meinz, J. Onishi, J. A. Marrinan, W. Li, G. K. Abruzzo, A. Flattery, K. Bartizal, A. Mitchell, and M. B. Kurtz. 1997. Identification of the FKS1 gene of Candida albicans as the essential target of the 1,3-β-D-glucan synthase inhibitors. Antimicrob. Agents Chemother. 41:2471-2479.
11. Douglas, C. M., F. Foor, J. A. Marrinan, N. Morin, J. B. Nielsen, A. M. Dahi, P. Mazur, W. Baginsky, W. Li, et al. 1994. The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. Proc. Natl. Acad. Sci. USA 20:12907-12911.
12. Dröse, S., and K. Altendorf. 1997. Bafilomycins and concanamycin as inhibitors of V-ATPases and P-ATPases. J. Exp. Biol. 200:1-8.
13. Dykstra, M. A., L. Friedman, and J. W. Murphy. 1977. Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect. Immun. 16:129-135.
14. Egner, R., F. E. Rosenthal, A. Kralli, D. Sanglard, and K. Kuchler. 1998. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-hinding cassette multidrug resistance transporter. Mol. Biol. Cell 9:523-543.
15. Eng, W. K., L. Faucette, M. M. McLaughlin, R. Cafferkey, Y. Koltin, R. A. Morris, P. R. Young, R. K. Johnson, and G. P. Livi. 1994. The yeast FKS1 gene encodes a novel membrane protein, mutations in which confer FK506 and cyclosporin A hypersensitivity and calcineurin-dependent growth. Gene 151:61-71.
16. Franzot, S. P., and A. Casadevall. 1997. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrob. Agents Chemother. 41:331-336.
17. +-ATPase. Mol. Cell. Biol. 15:4103-4114.
18. 1. Biochem. Biophys. Res. Commun. 170:873-878.
19. Hemenway, C. S., K. Dolinski, M. E. Cardenas, M. A. Hiller, E. W. Jones, and J. Heitman. 1995. vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. Genetics 141:833-844.
20. 2). Biochem. Biophys. Res. Commun. 216:589-594.
21. Jachez, B., D. Boesch, M. A. Grassberger, and F. Loor. 1993. Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK506 derivatives. Anticancer Drugs 4:223-229.
22. Kothe, G. O., and S. J. Free. 1998. Calcineurin subunit B is required for normal vegetative growth in Neurospora crassa. Fungal Genet. Biol. 23:248-258.
23. Kurtz, M. B., G. K. Abruzzo, A. Flattery, K. Bartizal, J. A. Marrinan, W. Li, J. Milligan, K. Nollstadt, and C. M. Douglas. 1996. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect. Immun. 64:3244-3251.
24. Kwon-Chung, K. J., I. Polacheck, and T. J. Popkin. 1982. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J. Bacteriol. 150:1414-1421.
25. +, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B. J. Bacteriol. 179:7653-7662.
26. Liu, J., J. D. Farmer, W. S. Lane, J. Friedman, I. Weissman, et al. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815.
27. Maesaki, S., P. Marichal, M. A. Hossain, D. Sanglard, H. Vanden Bossche, and S. Kohno. 1998. Synergic effects of tacrolimus and azole antifungal agent against azole-resistant Candida albicans strains. J. Antimicrob. Chemother. 42:747-753.
28. Mazur, P., N. Morin, W. Baginsky, M. El-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-β-D-glucan synthase. Mol. Cell. Biol. 15: 5671-5681.
29. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
30. Mizuno, K., Y. Furuhashi, T. Misawa, M. Iwata, M. Kawai, F. Kikkawa, T. Kano, and Y. Tomoda. 1992. Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. Anticancer Res. 12:21-25.
31. Monk, B. C., W. C. Feng, C. J. Marshall, D. Seto-Young, S. Na, J. E. Haber, and D. S. Perlin. 1994. Modeling a conformationally sensitive region of the membrane sector of the fungal plasma membrane proton pump. J. Bioenerg. Biomembr. 26:101-115.
32. Monk, B. C., and D. S. Perlin. 1994. Fungal membrane proton pumps as promising new antifungal targets. Crit. Rev. Microbiol. 20:209-223.
33. Moore, T. D. E., and J. C. Edman. 1993. The α-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol. Cell. Biol. 13:1962-1970.
34. Na, S., D. S. Perlin, D. Seto-Young, G. Wang, and J. B. Haber. 1993. Characterization of yeast plasma membrane H(+)-ATPase mutant pma1-A135V and its revertants. J. Biol. Chem. 268:11792-11797.
35. Naito, M., T. Oh-hara, A. Yamazaki, T. Danki, and T. Tsuruo. 1992. Reversal of multidrug resistance by an immunosuppressive agent, FK506. Cancer Chemother. Pharmacol. 29:195-200.
36. Nakamura, T., Y. Liu, D. Hirata, H. Namba, S. Harada, T. Hirokawa, and T. Miyakawa. 1993. Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. EMBO J. 12:4063-4071.
37. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution susceptibility testing of yeasts. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
38. Nelson, P. W., M. Lozano-Chiu, and J. H. Rex. 1996. In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions. J. Med. Vet. Mycol. 35:285-287.
39. Odom, A., M. Del Poeta, J. Perfect, and J. Heitman. 1997. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother. 41:156-161.
40. Odom, A., S. Muir, E. Lim, D. L. Toffaletti, J. Perfect, and J. Heitman. 1997. Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16:2576-2589.
41. Perfect, J. R., and D. T. Durack. 1985. Effects of cyclosporine in experimental cryptococcal meningitis. Infect. Immun. 50:22-26.
42. Perfect, J. R., D. L. Toffaletti, and T. H. Rude. 1993. The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid. Infect. Immun. 61:4446-4451.
43. Perlin, D. S., D. Seto-Young, and B. C. Monk. 1997. The plasma membrane H(+)-ATPase of fungi. A candidate drug target? Ann. N. Y. Acad. Sci. 834:609-617.
44. 2+ gradient. Mol. Gen. Genet. 256:104-114.
45. Rasmussen, C., C. Garen, S. Brining, R. L. Kincaid, R. L. Means, and A. R. Means. 1994. The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J. 13:2545-2552.
46. Raymond, M., S. Ruetz, D. Y. Thomas, and P. Gros. 1994. Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Mol. Cell. Biol. 14:277-286.
47. Rhodes, J. C., I. Polacheck, and K. J. Kwon-Chung. 1982. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36:1175-1184.
48. Sharom, J. F., X. Yu, J. W. K. Chu, and C. A. Doige. 1995. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem. J. 308:381-390.
49. Thompson, J. R., C. M. Douglas, W. Li, C. K. Jue, B. Pramanik, X. Yuan, T. H. Rude, D. L. Toffaletti, J. R. Perfect, and M. Kurtz. 1999. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function. J. Bacteriol. 181:444-453.
50. Vanden Bossche, H., F. Dromer, I. Improvisi, M. Lozano-Chiu, J. H. Rex, and D. Sanglard. 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36:119-128.
51. Vazquez, J. A., M. E. Lynch, D. Boikov, and J. D. Sobel. 1997. In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species. Antimicrob. Agents Chemother. 41:1612-1614.
52. 2+/CaM-dependent phosphatase (calcineurin) is improved by mutation in URE2 or PMA1. Genetics 149:865-878.
53. Yoshida, T., T. Toda, and M. Yanagida. 1994. A calcineurin-like gene ppb1+ in fission yeast: mutant defects in cytokinesis, cell polarity, mating and spindle pole body positioning. J. Cell Sci. 107:1725-1735.
54. Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022.